Skip to main content

Peer Review reports

From: Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review

Original Submission
27 Jan 2024 Submitted Original manuscript
24 Apr 2024 Reviewed Reviewer Report
5 May 2024 Reviewed Reviewer Report
6 Jun 2024 Author responded Author comments - Yefeng Chen
Resubmission - Version 2
6 Jun 2024 Submitted Manuscript version 2
13 Jun 2024 Reviewed Reviewer Report
28 Jun 2024 Author responded Author comments - Yefeng Chen
Resubmission - Version 3
28 Jun 2024 Submitted Manuscript version 3
Publishing
30 Jun 2024 Editorially accepted
8 Jul 2024 Article published 10.1186/s12890-024-03140-4

You can find further information about peer review here.

Back to article page